Nanocapsulated quercetin downregulates rat hepatic MMP-13 and controls diethylnitrosamine-induced carcinoma

The aims of our work were to investigate the controlling role and the efficacy of nanocapsulated quercetin drug delivery system on the decrement of inflammatory mediators such as MMP-13 in diethyl nitrosamine (DEN)-induced hepatocarcinogenesis. Hepatocellular carcinoma was developed in the Swiss alb...

Full description

Saved in:
Bibliographic Details
Published inNanomedicine (London, England) Vol. 9; no. 15; pp. 2323 - 2337
Main Authors Mandal, Ardhendu Kumar, Ghosh, Debasree, Sarkar, Sibani, Ghosh, Aparajita, Swarnakar, Snehasikta, Das, Nirmalendu
Format Journal Article
LanguageEnglish
Published London Future Medicine Ltd 01.10.2014
Future Medicine
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aims of our work were to investigate the controlling role and the efficacy of nanocapsulated quercetin drug delivery system on the decrement of inflammatory mediators such as MMP-13 in diethyl nitrosamine (DEN)-induced hepatocarcinogenesis. Hepatocellular carcinoma was developed in the Swiss albino rats by the exposure of DEN. DEN administration caused the generation of reactive oxygen species, upregulation of TNF-α, IL-6, activation of MMP-13, severe oxidative damage, hyperplastic nodules with preneoplastic lesions and the histopathological changes in rat liver. Nanocapsulated quercetin treatment restricted all alterations in DEN-mediated development of hepatocarcinogenesis. Therefore, it may be concluded that nanocapsulated quercetin may be accepted as a potent therapeutic formulation in preventing DEN-mediated hepatocarcinogenesis. Original submitted 4 January 2013; Revised submitted 2 December 2013
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1743-5889
1748-6963
DOI:10.2217/nnm.14.11